We reported that ACTL6A is amplification in ovarian cancer and silencing ACTL6A attenuated follicle-stimulating hormone (FSH)-driven glycolysis by downregulation of PGK1 (6). This evidence concerns the gene ACTL6A and ovarian carcinoma.